2BBBullish & Bearish
Foghorn Therapeutics Inc. (FHTX) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 16 out of 100.
Foghorn Therapeutics Inc.’s current 2BB score is 16 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 5 | Very Low |
| Momentum | 50 | Stable |
| Financial strength | 21 | Weak |
| Quality | 100 | Very Strong |
| Risk | 93 | Very High |
| Founded | 2015 |
| Employees | 106 |
| 52-week range | $1.79 – $7.61 |
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2027-03-09 | — | -0.2252 | — | $7.66M |
| 2026-11-03 | — | -0.2417 | — | $7.23M |
| 2026-08-11 | — | -0.261 | — | $6.11M |
| 2026-05-07 | -0.29 | -0.3111 | $3.27M | $7.59M |